Also known as acquired cutaneous adherence, it can also be caused by the chemotherapy medication doxorubicin and ketoconazole. ...
These include mitoxantrone, doxorubicin, paclitaxel, docetaxel, etoposide, dactinomycin, carfilzomib, sirolimus (rapamycin), ...
In particular, MDH2 has been found to be overexpressed in doxorubicin-resistant uterine cancer cells and may contribute to drug ... "Mitochondrial proteomics with siRNA knockdown to reveal ACAT1 and MDH2 in the development of doxorubicin-resistant uterine ...
... and doxorubicin-induced cardiomyopathy. Carnosine demonstrated neuroprotective effects in multiple animal studies. Research has ...
On the other hand, certain types of stress agents such as doxorubicin or ethidium bromide increase TNT formation. Other ...
The standard treatment for patients with diffuse large-B-cell lymphoma is cyclophosphamide, doxorubicin, vincristine, and ...
Rescues Doxorubicin Responsiveness via Down-Regulation of Multidrug Resistance 1" (pdf). Molecular Pharmacology. 78 (5): 855- ...
April 2009). "Phase II trial of tipifarnib plus neoadjuvant doxorubicin-cyclophosphamide in patients with clinical stage IIB- ...
Doxorubicin (Fig. 7) and the related derivatives daunorubicin, epirubicin, and idarubicin are anthracyclines obtained from the ... September 1988). "Protective effect of the bispiperazinedione ICRF-187 against doxorubicin-induced cardiac toxicity in women ...
Ye S, MacEachran DP, Hamilton JW, O'Toole GA, Stanton BA (2008). "Chemotoxicity of doxorubicin and surface expression of P- ...
Rescues Doxorubicin Responsiveness via Down-Regulation of Multidrug Resistance 1" (PDF). Molecular Pharmacology. 78 (5): 855- ...
Doxorubicin, a common cancer therapeutic, has been covalently coupled to an analogue of maurocalcine on drug-sensitive or drug- ... "Maurocalcine as a non toxic drug carrier overcomes doxorubicin resistance in the cancer cell line MDA-MB 231". Pharmaceutical ...
Combination trials have evaluated veliparib in combination with doxorubicin, temozolomide, topotecan, carboplatin, paclitaxel, ...
First, UCNPs can transport hydrophobic drugs, like doxorubicin, by encapsulating them on the particle surface, the hydrophobic ...
"Ascochlorin Enhances the Sensitivity of Doxorubicin Leading to the Reversal of Epithelial-to-Mesenchymal Transition in ...
... is a semisynthetic analog of the anthracycline doxorubicin, and is administered by infusion directly into the ...
A combination therapy of doxorubicin and sirolimus has been shown to drive Akt-positive lymphomas into remission in mice. Akt ... such as doxorubicin or cyclophosphamide. Sirolimus blocks Akt signalling and the cells lose their resistance to the ...
Vincristine, doxorubicin and bleomycin are used for adjuvant chemotherapy, but their effects are not good enough according to ...
It is a potent, selective, anticancer compound, with in vitro activity comparable to doxorubicin (IC50 = 3.1 μM against K562). ...
... is also used to minimize doxorubicin's cardiotoxic side effects and in the treatment of a patients with ...
... doxorubicin). Methotrexate has been seen to induce LG. Interferon alpha has been used by the US National Cancer Institute with ...
Chemotherapy drugs such as cyclophosphamide 1, fluorouracil, doxorubicin, cisplatin and mitomycin C were discovered to cause ...
It is usually idiopathic, but can also be caused by taurine deficiency in American Cocker Spaniels or doxorubicin use. A ...
In 2013 doxorubicin molecules (a popular cancer-killing drug) were bonded to nanodiamond surfaces, creating the drug ND-DOX. ...
An additional application of the CuInS2 quantum dots involved the drug delivery of an anticancer drug named doxorubicin (DOX). ...
R-CHOP consists of rituximab, three chemotherapy drugs (cyclophosphamide, doxorubicin, and vincristine) and a glucocorticoid ( ... doxorubicin, vincristine, and prednisone plus rituximab". Cancer. 118 (17): 4173-4183. doi:10.1002/cncr.27396. PMID 22213394. ...
Meanwhile, reduced expression of PRDX5 induces cell susceptibility to oxidative damage and etoposide, doxorubicin, MPP+, and ...
... doxorubicin and cyclophosphamide are reduced by 20% below the doses used in the previous cycle, but doxorubicin and etoposide ... If the nadir ANC > 500/μL, then the doses of etoposide, doxorubicin, and cyclophosphamide for the next cycle are all increased ... "Role of a Doxorubicin-Containing Regimen in Relapsed and Resistant Lymphomas: An 8-Year Follow-Up Study of EPOCH". Journal of ... also known as doxorubicin: an anthracycline antibiotic that is able to intercalate DNA, damaging it and preventing cell ...
Patients with neoplastic transformation of the tumours require chemotherapy; doxorubicin is thought to be the most effective ...
October 1991). "A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guérin for transitional- ...